NeuroPace Inc Insider Trading Activity
Every SEC Form 4 insider transaction reported for NeuroPace Inc (NPCE), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are NPCE insiders buying or selling?
In the last 12 months, NeuroPace Inc insiders reported 0 open-market purchases ($0) and 1 sale ($399.3K) — net selling of $399.3K. Since April 2021, Trabud has recorded 34 Form 4 filings for NPCE: 7 buys ($25.7M) and 27 sells ($65.3M).
Source: SEC EDGAR Form 4
Key Statistics (April 2021 – Mar 4, 2026)
Total Form 4 filings
34
SEC EDGAR
Insider filers
8
Insider buys (7)
$25.7M
Insider sells (27)
$65.3M
Insider sentiment
Net sellingNet insider flow of $39.6M in net selling since April 2021, and $399.3K in net selling over the last 12 months.
Recent NPCE insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Martha Morrell | CHIEF MEDICAL OFFICER | Sale | 25.0K | $15.97 | $399.3K | SEC ↗ |
| May 16, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Sale | 168.1K | $15.85 | $2.7M | SEC ↗ |
| Feb 25, 2025 | Martha Morrell | CHIEF MEDICAL OFFICER | Sale | 78.3K | $13.72 | $1.1M | SEC ↗ |
| Feb 20, 2025 | KCK LTD. | 10% Owner | Sale | 5.3M | $9.40 | $49.5M | SEC ↗ |
| Feb 1, 2025 | Martha Morrell | CHIEF MEDICAL OFFICER | Sale | 300 | $15.00 | $4.5K | SEC ↗ |
| Jan 28, 2025 | Martha Morrell | CHIEF MEDICAL OFFICER | Sale | 3.2K | $15.01 | $48.0K | SEC ↗ |
| Oct 28, 2024 | KCK LTD. | 10% Owner | Sale | 224.1K | $5.45 | $1.2M | SEC ↗ |
| Oct 24, 2024 | KCK LTD. | 10% Owner | Sale | 4.1K | $6.09 | $24.9K | SEC ↗ |
| Oct 22, 2024 | KCK LTD. | 10% Owner | Sale | 8.6K | $6.21 | $53.4K | SEC ↗ |
| Oct 18, 2024 | KCK LTD. | 10% Owner | Sale | 46.4K | $6.53 | $303.4K | SEC ↗ |
| Oct 3, 2024 | KCK LTD. | 10% Owner | Sale | 39.7K | $6.92 | $274.7K | SEC ↗ |
| May 3, 2024 | ORBIMED ADVISORS LLC | 10% Owner | Sale | 29.2K | $14.02 | $409.4K | SEC ↗ |
| Apr 26, 2024 | ORBIMED ADVISORS LLC | 10% Owner | Sale | 1.8K | $14.06 | $25.0K | SEC ↗ |
| Apr 23, 2024 | ORBIMED ADVISORS LLC | 10% Owner | Sale | 64.7K | $14.12 | $913.1K | SEC ↗ |
| Apr 18, 2024 | ORBIMED ADVISORS LLC | 10% Owner | Sale | 17.0K | $14.02 | $238.2K | SEC ↗ |
| Apr 15, 2024 | ORBIMED ADVISORS LLC | 10% Owner | Sale | 485.0K | $14.49 | $7.0M | SEC ↗ |
| Feb 7, 2024 | Martha Morrell | Chief Medical Officer | Sale | 17.6K | $15.09 | $265.4K | SEC ↗ |
| Feb 2, 2024 | Martha Morrell | Chief Medical Officer | Sale | 13.8K | $15.09 | $209.0K | SEC ↗ |
| Jan 26, 2024 | Martha Morrell | Chief Medical Officer | Sale | 828 | $15.02 | $12.4K | SEC ↗ |
| Dec 28, 2023 | Martha Morrell | Chief Medical Officer | Sale | 13.4K | $10.12 | $135.7K | SEC ↗ |
| Dec 22, 2023 | Martha Morrell | Chief Medical Officer | Sale | 2.7K | $10.14 | $27.7K | SEC ↗ |
| Dec 7, 2023 | Martha Morrell | Chief Medical Officer | Sale | 11.0K | $8.16 | $89.8K | SEC ↗ |
| Dec 2, 2023 | KCK LTD. | 10% Owner | Sale | 16.2K | $8.78 | $141.9K | SEC ↗ |
| Nov 29, 2023 | KCK LTD. | 10% Owner | Sale | 11.2K | $8.87 | $99.1K | SEC ↗ |
| Oct 4, 2023 | ORBIMED ADVISORS LLC | 10% Owner | Sale | 8.3K | $9.07 | $75.4K | SEC ↗ |
Showing the 25 most recent of 34 Form 4 filings for NeuroPace Inc.
Most active NPCE insiders
- Martha Morrell10 filings
- KCK LTD.8 filings
- ORBIMED ADVISORS LLC8 filings
- Irina Ridley3 filings
- Accelmed Partners II L.P.2 filings
Ask anything about NPCE insider activity
Use Trabud's AI agent to query NeuroPace Inc's Form 4 history in plain English — "Show me NPCE CEO purchases this year" or compare it against any other ticker.
Open the AI agentNPCE insider trading FAQ
Are NeuroPace Inc insiders buying or selling?
In the last 12 months, NeuroPace Inc insiders reported 0 open-market purchases ($0) and 1 sale ($399.3K) — net selling of $399.3K. Since April 2021, Trabud has recorded 34 Form 4 filings for NPCE: 7 buys ($25.7M) and 27 sells ($65.3M). Over the full record that is net selling of $39.6M.
How many insiders trade NPCE stock?
8 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for NeuroPace Inc. The most recent filing was accepted on Mar 4, 2026.
Where does Trabud get NPCE insider trading data?
All NPCE insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.